EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Recent advances in bacteria‐based platforms for inflammatory bowel diseases treatment

Jiaoying Lu, Xinyuan Shen, Hongjun Li iD, Juan Du

Exploration · 2024-10 · 4 (5)

DOI: 10.1002/exp.20230142 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Exploration, online erschienen am 05.03.2024. Verfasst von Jiaoying Lu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology The First Affiliated Hospital School of Medicine Zhejiang University Hangzhou China. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 138 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammatory bowel disease (IBD) is a recurring chronic inflammatory disease. Current treatment strategies are aimed at alleviating clinical symptoms and are associated with gastrointestinal or systemic adverse effects. New delivery strategies are needed for the treatment of IBD. Bacteria are promising biocarriers, which can produce drugs in situ and sense the gut in real time. Herein, we focus on recent studies of engineered bacteria used for IBD treatment and introduce the application of engineered bacteria in the diagnosis. On this basis, the current dilemmas and future developments of bacterial delivery systems are discussed.

Schlagwörter

Stichwörter der Autor:innen

diagnosisdrug deliveryengineered bacteriainflammatory bowel diseases

Autor:innen und Institutionen

  • Department of Gastroenterology The First Affiliated Hospital School of Medicine Zhejiang University Hangzhou China.
  • National Key Laboratory of Advanced Drug Delivery and Release Systems College of Pharmaceutical Sciences Zhejiang University Hangzhou China.
  • Department of Bioengineering University of California Los Angeles California USA.
  • Department of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital School of Medicine Zhejiang University Hangzhou Zhejiang China.
  • Liangzhu Laboratory Zhejiang University Hangzhou China.

ORCID-Profile: Hongjun Li

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Lu, J., Shen, X., Li, H., & Du, J. (2024). Recent advances in bacteria‐based platforms for inflammatory bowel diseases treatment. Exploration, 4(5). https://doi.org/10.1002/exp.20230142

Vancouver

Lu J, Shen X, Li H, Du J. Recent advances in bacteria‐based platforms for inflammatory bowel diseases treatment. Exploration. 2024;4(5). doi:10.1002/exp.20230142

BibTeX
@article{Lu2024,
  author = {Lu, Jiaoying and Shen, Xinyuan and Li, Hongjun and Du, Juan},
  title = {Recent advances in bacteria‐based platforms for inflammatory bowel diseases treatment},
  journal = {Exploration},
  year = {2024},
  volume = {4},
  number = {5},
  doi = {10.1002/exp.20230142}
}
Kostenlos starten →